Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Galli

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
BMJ Open|January 5, 2023
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohortSilvia Nozza, Angelo Roberto Raccagni, Riccardo Lolatto, et al.
AIDS (London, England)|February 16, 2010
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experienceSilvia Nozza, Laura Galli, Francesca Visco, et al.
Viruses|July 30, 2025
Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of SteatosisAlessia Siribelli, Sara Diotallevi, Laura Galli, et al.
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapineRosa Maria Moresco, Roberto Cavallaro, Cristina Messa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2013
Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugsHamid Hasson, Marco Merli, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2012
Immune recovery and T cell subset analysis during effective treatment with maravirocFrancesca Cossarini, Andrea Galli, Laura Galli, et al.
AIDS (London, England)|April 8, 2021
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimenNicola Gianotti, Laura Galli, Andrea Poli, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2024
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life settingRebecka Papaioannu Borjesson, Tommaso Clemente, Sara Diotallevi, et al.
International Journal of Antimicrobial Agents|June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life settingTommaso Clemente, Laura Galli, Andrea Poli, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 17, 2007
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progressionGiulia Morsica, Sabrina Bagaglio, Silvia Ghezzi, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
BMJ Open|January 5, 2023
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohortSilvia Nozza, Angelo Roberto Raccagni, Riccardo Lolatto, et al.
AIDS (London, England)|February 16, 2010
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experienceSilvia Nozza, Laura Galli, Francesca Visco, et al.
Viruses|July 30, 2025
Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of SteatosisAlessia Siribelli, Sara Diotallevi, Laura Galli, et al.
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapineRosa Maria Moresco, Roberto Cavallaro, Cristina Messa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2013
Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugsHamid Hasson, Marco Merli, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2012
Immune recovery and T cell subset analysis during effective treatment with maravirocFrancesca Cossarini, Andrea Galli, Laura Galli, et al.
AIDS (London, England)|April 8, 2021
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimenNicola Gianotti, Laura Galli, Andrea Poli, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2024
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life settingRebecka Papaioannu Borjesson, Tommaso Clemente, Sara Diotallevi, et al.
International Journal of Antimicrobial Agents|June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life settingTommaso Clemente, Laura Galli, Andrea Poli, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 17, 2007
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progressionGiulia Morsica, Sabrina Bagaglio, Silvia Ghezzi, et al.
Pageof 18